UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Management of Obesity in People with Severe Mental Illness: An Unresolved Conundrum

Psychotherapy and psychosomatics, 2019-11, Vol.88 (6), p.327-332

Holt, Richard I.G.

2019

Volltextzugriff (PDF)

Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation

Diabetes care, 2013-10, Vol.36 (10), p.3337-3345

2013

Volltextzugriff (PDF)

Diabetes mellitus and severe mental illness: mechanisms and clinical implications

Nature reviews. Endocrinology, 2015-02, Vol.11 (2), p.79-89

2015

Volltextzugriff (PDF)

The Use and Abuse of Growth Hormone in Sports

Endocrine reviews, 2019-08, Vol.40 (4), p.1163-1185

2019

Volltextzugriff (PDF)

Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation: Systematic review

Diabetes care, 2013-10, Vol.36 (10), p.3337-3345

2013

Volltextzugriff (PDF)

Obesity, serious mental illness and antipsychotic drugs

Diabetes, obesity & metabolism, 2009-07, Vol.11 (7), p.665-679

2009

Volltextzugriff (PDF)

Correlates and outcomes of worries about hypoglycemia in family members of adults with diabetes: The second Diabetes Attitudes, Wishes and Needs (DAWN2) study

Journal of psychosomatic research, 2016-10, Vol.89, p.69-77

2016

Volltextzugriff (PDF)

The relationship between depression, anxiety and cardiovascular disease: Findings from the Hertfordshire Cohort Study

Journal of affective disorders, 2013-08, Vol.150 (1), p.84-90

2013

Volltextzugriff (PDF)

Dialogue on Diabetes and Depression: Dealing with the double burden of co-morbidity

Journal of affective disorders, 2012-10, Vol.142, p.S1-S3

2012

Volltextzugriff (PDF)

Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder

Clinical drug investigation, 2011-01, Vol.31 (7), p.455-482

2011

Volltextzugriff (PDF)

A new measure of multimorbid illness and treatment representations: The example of diabetes and depression

Journal of affective disorders, 2015-03, Vol.174, p.192-200

2015

Volltextzugriff (PDF)

Fetal programming of the growth hormone–insulin-like growth factor axis

Trends in Endocrinology & Metabolism, 2002-11, Vol.13 (9), p.392-397

Holt, Richard I.G

2002

Volltextzugriff (PDF)

Household composition and psychological health: Results of the second Diabetes Attitudes, Wishes and Needs (DAWN2) study

Journal of diabetes and its complications, 2017-02, Vol.31 (2), p.340-346

2017

Volltextzugriff (PDF)

Diabetes in psychiatric disease

Medicine (Abingdon. 1995, UK ed.), 2015-01, Vol.43 (1), p.51-53

Holt, Richard I.G

2015

Volltextzugriff (PDF)

The history of doping and growth hormone abuse in sport

Growth hormone & IGF research, 2009-08, Vol.19 (4), p.320-326

2009

Volltextzugriff (PDF)

Key concepts in screening for depression in people with diabetes

Journal of affective disorders, 2012-10, Vol.142, p.S72-S79

2012

Volltextzugriff (PDF)

The fifth UK paediatric diabetes services survey: meeting guidelines and recommendations?

Archives of disease in childhood, 2010-10, Vol.95 (10), p.837-840

2010

Volltextzugriff (PDF)

The DIAMONDS intervention to support self-management of type 2 diabetes in people with severe mental illness: Study protocol for a single-group feasibility study

SSM - mental health, 2022-12, Vol.2, p.100086, Article 100086

2022

Volltextzugriff (PDF)

Textbook of diabetes, fourth edition

4th ed., 2010

Volltextzugriff (PDF)

Association Between Antipsychotic Medication Use and Diabetes

Current diabetes reports, 2019-10, Vol.19 (10), p.96-10, Article 96

Holt, Richard I. G.

2019

Volltextzugriff (PDF)

Diabetes in psychiatric disease

Medicine (Abingdon. 1995, UK ed.), 2022-11, Vol.50 (11), p.741-744

Holt, Richard I.G.

2022

Volltextzugriff (PDF)

Challenges in Detecting the Abuse of Growth Hormone in Sport

Clinical chemistry (Baltimore, Md.), 2005-09, Vol.51 (9), p.1587-1593

2005

Volltextzugriff (PDF)

Osteoporosis in people with severe mental illness: A forgotten condition

Maturitas, 2010-09, Vol.67 (1), p.1-2

Holt, Richard I.G

2010

Volltextzugriff (PDF)

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetes care, 2021-11, Vol.44 (11), p.2589-2625

2021

Volltextzugriff (PDF)

The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays

Growth hormone & IGF research, 2012-04, Vol.22 (2), p.53-58

2012

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(177)

Publikationsform

Artikel
(179)
Buchkapitel
(95)
Bücher
(5)

Sprache

Englisch
(279)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The Management of Obesity in People with Severe Mental Illness: An Unresolved Conundrum

Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation

Diabetes mellitus and severe mental illness: mechanisms and clinical implications

The Use and Abuse of Growth Hormone in Sports

Antidepressant Medication as a Risk Factor for Type 2 Diabetes and Impaired Glucose Regulation: Systematic review

Obesity, serious mental illness and antipsychotic drugs

Correlates and outcomes of worries about hypoglycemia in family members of adults with diabetes: The second Diabetes Attitudes, Wishes and Needs (DAWN2) study

The relationship between depression, anxiety and cardiovascular disease: Findings from the Hertfordshire Cohort Study

Dialogue on Diabetes and Depression: Dealing with the double burden of co-morbidity

Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder

A new measure of multimorbid illness and treatment representations: The example of diabetes and depression

Fetal programming of the growth hormone–insulin-like growth factor axis

Household composition and psychological health: Results of the second Diabetes Attitudes, Wishes and Needs (DAWN2) study

Diabetes in psychiatric disease

The history of doping and growth hormone abuse in sport

Key concepts in screening for depression in people with diabetes

The fifth UK paediatric diabetes services survey: meeting guidelines and recommendations?

The DIAMONDS intervention to support self-management of type 2 diabetes in people with severe mental illness: Study protocol for a single-group feasibility study

Textbook of diabetes, fourth edition

Association Between Antipsychotic Medication Use and Diabetes

Diabetes in psychiatric disease

Challenges in Detecting the Abuse of Growth Hormone in Sport

Osteoporosis in people with severe mental illness: A forgotten condition

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays

Suchergebnisse filtern